Related Experiment Video
Updated: May 15, 2025
07:12
A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
Published on: November 24, 2020
5.0K
D-chiro-inositol effectively counteracts endometriosis in a mouse model
Martina Placidi1, Giovanni Casoli1, Teresa Vergara1
1Department of Life, Health and Environmental Sciences, University of L'Aquila, Via G. Petrini, 67100, L'Aquila, Italy.
Molecular Medicine (Cambridge, Mass.)
|April 11, 2025
Summary
D-chiro inositol (DCI) effectively reduced endometriosis lesion growth in mice by impacting proliferation and vascularization. DCI also positively influenced ovarian function, suggesting its potential as a novel endometriosis treatment.
Area of Science:
- Reproductive biology
- Endocrinology
- Pharmacology
Background:
- Endometriosis affects 5-10% of reproductive-age women, causing pain and infertility.
- Current treatments like surgery and hormonal therapy have limited long-term efficacy.
- D-chiro inositol (DCI) influences ovarian steroidogenesis and was investigated for endometriosis treatment.
Purpose of the Study:
- To investigate the therapeutic potential of D-chiro inositol (DCI) for endometriosis.
- To compare the efficacy of DCI with Dienogest (DG), a progestin drug.
- To elucidate the molecular mechanisms underlying DCI's effects on endometriosis.
Main Methods:
- A non-surgical mouse model of endometriosis was established.
- Mice received water (control), DCI, DCI + DG, or DG for 28 days.
- Endometriotic lesions, ovaries, and estradiol levels were analyzed post-treatment.
Main Results:
- DCI significantly reduced lesion number, size, and vascularization, outperforming DG in some aspects.
- DCI decreased Sirt1 expression and increased E-Cadherin, inhibiting epithelial-mesenchymal transition (EMT).
- DCI downregulated aromatase (Cyp19a1) expression and improved ovarian folliculogenesis.
Conclusions:
- DCI demonstrates significant efficacy in reducing endometriosis progression.
- DCI modulates key pathways including proliferation, EMT, and aromatase activity.
- DCI is a promising natural compound for endometriosis treatment, potentially offering benefits for ovarian function.
